Publisher correction: first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
31 January 2024
|
| In: |
Nature medicine
Year: 2024, Jahrgang: 30, Heft: 5, Pages: 1505 |
| ISSN: | 1546-170X |
| DOI: | 10.1038/s41591-024-02835-9 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41591-024-02835-9 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41591-024-02835-9 |
| Verfasserangaben: | Karim Fizazi, Arun A. Azad, Nobuaki Matsubara, Joan Carles, Andre P. Fay, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G. Healy, Nicola Di Santo, A. Douglas Laird, Fabian Zohren & Neeraj Agarwal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1881105873 | ||
| 003 | DE-627 | ||
| 005 | 20250324110809.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240219s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41591-024-02835-9 |2 doi | |
| 035 | |a (DE-627)1881105873 | ||
| 035 | |a (DE-599)KXP1881105873 | ||
| 035 | |a (OCoLC)1425200232 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Fizazi, Karim |e VerfasserIn |0 (DE-588)138277079 |0 (DE-627)601096843 |0 (DE-576)306985349 |4 aut | |
| 245 | 1 | 0 | |a Publisher correction |b first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial |c Karim Fizazi, Arun A. Azad, Nobuaki Matsubara, Joan Carles, Andre P. Fay, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G. Healy, Nicola Di Santo, A. Douglas Laird, Fabian Zohren & Neeraj Agarwal |
| 264 | 1 | |c 31 January 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.02.2024 | ||
| 650 | 4 | |a Prostate cancer | |
| 700 | 1 | |a Azad, Arun A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Matsubara, Nobuaki |e VerfasserIn |4 aut | |
| 700 | 1 | |a Carles, Joan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fay, Andre P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Giorgi, Ugo de |e VerfasserIn |0 (DE-588)1165676915 |0 (DE-627)102976168X |0 (DE-576)510496466 |4 aut | |
| 700 | 1 | |a Joung, Jae Young |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fong, Peter C. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Voog, Eric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jones, Robert J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shore, Neal D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dunshee, Curtis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zschäbitz, Stefanie |d 1983- |e VerfasserIn |0 (DE-588)1037698827 |0 (DE-627)75589894X |0 (DE-576)391727206 |4 aut | |
| 700 | 1 | |a Oldenburg, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ye, Dingwei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lin, Xun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Healy, Cynthia G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Di Santo, Nicola |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laird, A. Douglas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zohren, Fabian |d 1976- |e VerfasserIn |0 (DE-588)136173098 |0 (DE-627)577208950 |0 (DE-576)300874766 |4 aut | |
| 700 | 1 | |a Agarwal, Neeraj |e VerfasserIn |0 (DE-588)1305704665 |0 (DE-627)1861542879 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d [New York, NY] : Springer Nature, 1995 |g 30(2024), 5, Seite 1505 |h Online-Ressource |w (DE-627)301511640 |w (DE-600)1484517-9 |w (DE-576)288571274 |x 1546-170X |7 nnas |a Publisher correction first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:5 |g pages:1505 |a Publisher correction first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial |
| 787 | 0 | 8 | |i Ergänzung zu |a Fizazi, Karim |t First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer |d 2024 |w (DE-627)1881104362 |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41591-024-02835-9 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41591-024-02835-9 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240219 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1037698827 |a Zschäbitz, Stefanie |m 1037698827:Zschäbitz, Stefanie |d 910000 |d 910100 |e 910000PZ1037698827 |e 910100PZ1037698827 |k 0/910000/ |k 1/910000/910100/ |p 13 | ||
| 999 | |a KXP-PPN1881105873 |e 4487423414 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Karim","family":"Fizazi","display":"Fizazi, Karim"},{"display":"Azad, Arun A.","family":"Azad","given":"Arun A.","role":"aut"},{"family":"Matsubara","display":"Matsubara, Nobuaki","role":"aut","given":"Nobuaki"},{"role":"aut","given":"Joan","display":"Carles, Joan","family":"Carles"},{"given":"Andre P.","role":"aut","family":"Fay","display":"Fay, Andre P."},{"family":"Giorgi","display":"Giorgi, Ugo de","given":"Ugo de","role":"aut"},{"display":"Joung, Jae Young","family":"Joung","role":"aut","given":"Jae Young"},{"role":"aut","given":"Peter C. C.","family":"Fong","display":"Fong, Peter C. C."},{"family":"Voog","display":"Voog, Eric","role":"aut","given":"Eric"},{"display":"Jones, Robert J.","family":"Jones","given":"Robert J.","role":"aut"},{"given":"Neal D.","role":"aut","display":"Shore, Neal D.","family":"Shore"},{"family":"Dunshee","display":"Dunshee, Curtis","given":"Curtis","role":"aut"},{"display":"Zschäbitz, Stefanie","family":"Zschäbitz","role":"aut","given":"Stefanie"},{"family":"Oldenburg","display":"Oldenburg, Jan","given":"Jan","role":"aut"},{"role":"aut","given":"Dingwei","display":"Ye, Dingwei","family":"Ye"},{"family":"Lin","display":"Lin, Xun","role":"aut","given":"Xun"},{"given":"Cynthia G.","role":"aut","display":"Healy, Cynthia G.","family":"Healy"},{"given":"Nicola","role":"aut","family":"Di Santo","display":"Di Santo, Nicola"},{"family":"Laird","display":"Laird, A. Douglas","role":"aut","given":"A. Douglas"},{"display":"Zohren, Fabian","family":"Zohren","role":"aut","given":"Fabian"},{"role":"aut","given":"Neeraj","family":"Agarwal","display":"Agarwal, Neeraj"}],"origin":[{"dateIssuedDisp":"31 January 2024","dateIssuedKey":"2024"}],"note":["Gesehen am 19.02.2024"],"title":[{"title_sort":"Publisher correction","subtitle":"first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial","title":"Publisher correction"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1881105873","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"301511640","id":{"issn":["1546-170X"],"zdb":["1484517-9"],"eki":["301511640"]},"title":[{"title_sort":"Nature medicine","title":"Nature medicine"}],"origin":[{"publisherPlace":"[New York, NY] ; New York, NY","dateIssuedDisp":"2017-","publisher":"Springer Nature ; Nature America Inc.","dateIssuedKey":"2017"}],"pubHistory":["1.1995 -"],"note":["Gesehen am 24. Juli 2018"],"disp":"Publisher correction first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trialNature medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"volume":"30","issue":"5","text":"30(2024), 5, Seite 1505","year":"2024","pages":"1505"}}],"name":{"displayForm":["Karim Fizazi, Arun A. Azad, Nobuaki Matsubara, Joan Carles, Andre P. Fay, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G. Healy, Nicola Di Santo, A. Douglas Laird, Fabian Zohren & Neeraj Agarwal"]},"language":["eng"],"id":{"eki":["1881105873"],"doi":["10.1038/s41591-024-02835-9"]}} | ||
| SRT | |a FIZAZIKARIPUBLISHERC3120 | ||